Almost 30 years after its initial discovery, infection with the human immunodeficiency virus-1 (HIV-1) remains incurable and the virus persists due to reservoirs of latently infected CD4+ memory T-cells and sanctuary sites within the infected individual where drug penetration is poor. Reactivating latent viruses has been a key strategy to completely eliminate the virus from the host, but many difficulties and unanswered questions remain. In this review, the latest developments in HIV-persistence and latency research are presented
Aids has become the leading cause of death world-wide. Much research has been done on the causal age...
In a patient infected with HIV-1, the presence of latently infected cells from which the virus can b...
The use of combination antiretroviral therapy (ART) has resulted in a substantial reduction in virem...
Almost 30 years after its initial discovery, infection with the human immunodeficiency virus-1 (HIV-...
The major obstacle towards HIV-1 eradication is the life-long persistence of the virus in reservoirs...
International audienceCurrent therapies do not eradicate HIV from infected patients. Indeed, HIV hid...
Despite significant advances in our understanding of HIV, a cure has not been realized for the more ...
Despite significant advances in our understanding of HIV, a cure has not been realized for the more ...
When HIV infects host immune cells, it inserts its genetic material into their DNA enabling the viru...
Quiescent proviral genomes that persist during human immunodeficiency virus type 1 (HIV-1) infection...
In chronic human immunodeficiency virus (HIV)-1 infection, long-lived latently infected cells are th...
In chronic human immunodeficiency virus (HIV)-1 infection, long-lived latently infected cells are th...
In chronic human immunodeficiency virus (HIV)-1 infection, long-lived latently infected cells are th...
In a patient infected with HIV-1, the presence of latently infected cells from which the virus can b...
HIV-1 infection persists even after years of antiretroviral therapy (ART). Although ART can halt vir...
Aids has become the leading cause of death world-wide. Much research has been done on the causal age...
In a patient infected with HIV-1, the presence of latently infected cells from which the virus can b...
The use of combination antiretroviral therapy (ART) has resulted in a substantial reduction in virem...
Almost 30 years after its initial discovery, infection with the human immunodeficiency virus-1 (HIV-...
The major obstacle towards HIV-1 eradication is the life-long persistence of the virus in reservoirs...
International audienceCurrent therapies do not eradicate HIV from infected patients. Indeed, HIV hid...
Despite significant advances in our understanding of HIV, a cure has not been realized for the more ...
Despite significant advances in our understanding of HIV, a cure has not been realized for the more ...
When HIV infects host immune cells, it inserts its genetic material into their DNA enabling the viru...
Quiescent proviral genomes that persist during human immunodeficiency virus type 1 (HIV-1) infection...
In chronic human immunodeficiency virus (HIV)-1 infection, long-lived latently infected cells are th...
In chronic human immunodeficiency virus (HIV)-1 infection, long-lived latently infected cells are th...
In chronic human immunodeficiency virus (HIV)-1 infection, long-lived latently infected cells are th...
In a patient infected with HIV-1, the presence of latently infected cells from which the virus can b...
HIV-1 infection persists even after years of antiretroviral therapy (ART). Although ART can halt vir...
Aids has become the leading cause of death world-wide. Much research has been done on the causal age...
In a patient infected with HIV-1, the presence of latently infected cells from which the virus can b...
The use of combination antiretroviral therapy (ART) has resulted in a substantial reduction in virem...